Report on the risk assessment of methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-MDMB-PINACA) in the framework of the Council Decision on new psychoactive substances 16. July 2018, section EUDA news
17. December 2025 Shedding light on drug-related hospital emergencies in Europe Every year, thousands of people across Europe require hospital treatment for drug-related poisoning and other acute harms. In...